Scynexis announces pricing
Webb1 dec. 2024 · SCYNEXIS has initiated the launch of its first commercial product in the U.S., BREXAFEMME ® (ibrexafungerp tablets). The U.S. Food and Drug Administration (FDA) approved BREXAFEMME on June 1, 2024 , for its first indication in vulvovaginal candidiasis (VVC), followed by a second indication on November 30, 2024 , for reduction in the … Webb6 mars 2024 · JERSEY CITY, N.J., March 6, 2024 /PRNewswire/ -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the pricing of its underwritten public offering of common stock …
Scynexis announces pricing
Did you know?
WebbFind the latest SCYNEXIS, Inc. (SCYX) stock quote, history, news and other vital information to help you with your stock trading and investing. Webb22 apr. 2024 · JERSEY CITY, N.J., April 22, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq: SCYX) today announced the pricing of its underwritten public offering of …
Webb21 juni 2016 · JERSEY CITY, N.J., June 21, 2016 -- SCYNEXIS, Inc. today announced the pricing of its underwritten public offering of 9,375,000 shares of its common stock and … http://ir.scynexis.com/news/detail/197/scynexis-announces-pricing-of-35-million-public-offering-of-common-stock-and-warrants
WebbThe gross offering proceeds to SCYNEXIS from this offering are expected to be approximately $85.0 million, before deducting the underwriting discount and other … Webb17 dec. 2024 · JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the pricing of its underwritten public offering of common stock, pre-funded warrants and warrants. The shares and warrants are being sold at a public offering price of $6.25 per share and accompanying warrants, and the pre-funded …
Webb10 feb. 2024 · SCYNEXIS Announces Positive Results from Its Pivotal Phase 3 CANDLE Study of Oral Ibrexafungerp for Prevention of Recurrent Vaginal Yeast Infections, Clearing the Way for Regulatory Submission...
WebbBiotech highlight: SCYNEXIS (SCYX) Back to back announcements of good news. This is a relatively new one for me in this space, but the news (in links below) of the NIH grant followed by the FDA approval of an additional indication will make following today's stock-price-action of interest! www.scynexis.com www.scynexis.com (NOTE: NO Back to back … ozarks farm and neighborWebb17 dec. 2024 · SCYNEXIS Announces Pricing of $85 Million Public Offering of Common Stock, Pre-Funded Warrants and Warrants. JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) ... The gross offering proceeds to SCYNEXIS from this offering are expected to be approximately $85.0 million, ... jelly comb pocket keyboardWebb21 juni 2016 · JERSEY CITY, N.J., June 21, 2016 -- SCYNEXIS, Inc. today announced the pricing of its underwritten public offering of 9,375,000 shares of its common stock and warrants to purchase 4,218,750... April 4, 2024 ozarks extreme outdoors branson moWebbH.C. Wainwright & Co. is acting as sole book-running manager for the offering. The warrants will have an exercise price of $1.10 per share and exercise period commencing immediately upon issuance and an expiration date of the earlier of (i) such date that is six months after SCYNEXIS publicly announces the approval from the U.S. Food and Drug … jelly comb rechargeable wireless touchpadWebb17 dec. 2024 · 17.12.2024 - JERSEY CITY, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) - SCYNEXIS, Inc. (Nasdaq:SCYX) today announced the pricing of its underwritten public offering of common stock, pre-funded warrants ... ozarks federal credit unionWebb26 apr. 2024 · The shares and warrants were sold at a public offering price of $3.00 per share and accompanying warrants, and the pre-funded warrants were sold at a public … jelly comb replacement bluetooth receiverWebbSCYNEXIS Announces Pricing of $35 Million Public Offering of Common Stock and Warrants December 10, 2024 6:22am EST Download as PDF H.C. Wainwright & Co. is … jelly comb review